117 related articles for article (PubMed ID: 38550039)
1. Retracted: Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme.
International BR
Biomed Res Int; 2024; 2024():9756795. PubMed ID: 38550039
[TBL] [Abstract][Full Text] [Related]
2. Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme.
Wang K; Lu Y; Liu Z; Diao M; Yang L
Biomed Res Int; 2022; 2022():7858477. PubMed ID: 35155681
[TBL] [Abstract][Full Text] [Related]
3. Retracted: Establishment and Validation of an MTORC1 Signaling-Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9851737. PubMed ID: 38549990
[TBL] [Abstract][Full Text] [Related]
4. Retracted: N-myc Downstream-Regulated Gene 1 (NDRG1) Regulates Vascular Endothelial Growth Factor A (VEGFA) and Malignancies in Glioblastoma Multiforme (GBM).
International BR
Biomed Res Int; 2023; 2023():9794063. PubMed ID: 37829051
[TBL] [Abstract][Full Text] [Related]
5. Retracted: Value of a Signature of Immune-Related Genes in Predicting the Prognosis of Melanoma and Its Responses to Immune Checkpoint Blocker Therapies.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9781954. PubMed ID: 37416155
[TBL] [Abstract][Full Text] [Related]
6. Retracted: Establishment and Validation for Predicting the Death of Multiple Myeloma among Whites.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9871636. PubMed ID: 37501834
[TBL] [Abstract][Full Text] [Related]
7. Identification of Hypoxia Prognostic Signature in Glioblastoma Multiforme Based on Bulk and Single-Cell RNA-Seq.
Ahmed YB; Ababneh OE; Al-Khalili AA; Serhan A; Hatamleh Z; Ghammaz O; Alkhaldi M; Alomari S
Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339384
[TBL] [Abstract][Full Text] [Related]
8. Computational identification of immune-related lncRNA signature for predicting the prognosis and immune landscape of human glioblastoma multiforme.
Shi D; Zhong W; Liu D; Sun X; Hao S; Yang Y; Ao L; Zhou J; Xia Y; Zhou Y; Yu H; Xia H
Front Immunol; 2022; 13():932938. PubMed ID: 36032137
[TBL] [Abstract][Full Text] [Related]
9. Retracted: Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma.
International BR
Biomed Res Int; 2022; 2022():9829634. PubMed ID: 36605105
[TBL] [Abstract][Full Text] [Related]
10. Identification of T-cell exhaustion-related gene signature for predicting prognosis in glioblastoma multiforme.
Liu YH; Jin HQ; Liu HP
J Cell Mol Med; 2023 Nov; 27(22):3503-3513. PubMed ID: 37635346
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a novel mitophagy-related gene prognostic signature for glioblastoma multiforme.
Wang J; Qiu X; Huang J; Zhuo Z; Chen H; Zeng R; Wu H; Guo K; Yang Q; Ye H; Huang W; Luo Y
BMC Cancer; 2022 Jun; 22(1):644. PubMed ID: 35692054
[TBL] [Abstract][Full Text] [Related]
12. Retracted: Establishment and Verification of a Gene Signature for Diagnosing Type 2 Diabetics by WGCNA, LASSO Analysis, and In Vitro Experiments.
International BR
Biomed Res Int; 2024; 2024():9828614. PubMed ID: 38550194
[TBL] [Abstract][Full Text] [Related]
13. Retracted: Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature.
International BR
Biomed Res Int; 2024; 2024():9850107. PubMed ID: 38550181
[TBL] [Abstract][Full Text] [Related]
14. Retracted: A Ferroptosis-Related Gene Signature for Predicting Survival and Immunotherapy Effect in Renal Cancer.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9835478. PubMed ID: 37503419
[TBL] [Abstract][Full Text] [Related]
15. Retracted: Development of a Bile Acid-Related Gene Signature for Predicting Survival in Patients with Hepatocellular Carcinoma.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9865740. PubMed ID: 38094394
[TBL] [Abstract][Full Text] [Related]
16. An Immune-Related Six-lncRNA Signature to Improve Prognosis Prediction of Glioblastoma Multiforme.
Zhou M; Zhang Z; Zhao H; Bao S; Cheng L; Sun J
Mol Neurobiol; 2018 May; 55(5):3684-3697. PubMed ID: 28527107
[TBL] [Abstract][Full Text] [Related]
17. Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma.
Prasad B; Tian Y; Li X
Mol Neurobiol; 2020 Dec; 57(12):5235-5246. PubMed ID: 32875483
[TBL] [Abstract][Full Text] [Related]
18. A risk signature with four autophagy-related genes for predicting survival of glioblastoma multiforme.
Wang Y; Zhao W; Xiao Z; Guan G; Liu X; Zhuang M
J Cell Mol Med; 2020 Apr; 24(7):3807-3821. PubMed ID: 32065482
[TBL] [Abstract][Full Text] [Related]
19. Retracted: Establishment and Analysis of Hypoxia-Related Model in Oral Squamous Cell Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9898076. PubMed ID: 37860331
[TBL] [Abstract][Full Text] [Related]
20. Combined targeting of PDK1 and EGFR triggers regression of glioblastoma by reversing the Warburg effect.
Velpula KK; Bhasin A; Asuthkar S; Tsung AJ
Cancer Res; 2013 Dec; 73(24):7277-89. PubMed ID: 24148623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
